STOCK TITAN

ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ESSA Pharma Inc. (Nasdaq: EPIX) announced that CEO Dr. David R. Parkinson will present at the Bloom Burton & Co. Healthcare Investor Conference on April 20, 2021, at 11:00 AM ET. The presentation will last 30 minutes and include a Q&A session. Dr. Parkinson, COO Peter Virsik, and CFO David S. Wood will also hold one-on-one meetings. Attendees can access the presentation via a webcast on ESSA's website, available for 90 days post-event. The conference aims to update investors on developments within the Canadian healthcare sector.

Positive
  • None.
Negative
  • None.

HOUSTON, Texas and VANCOUVER, Canada, April 14, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Dr. David R. Parkinson, Chief Executive Officer of ESSA Pharma, will be presenting at the upcoming Bloom Burton & Co. Healthcare Investor Conference, taking place virtually April 20-21, 2021. Dr. Parkinson, along with Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.

Presentation Details

Date: Tuesday, April 20, 2021
Time: 11:00 AM ET
Format: 30-minute virtual company presentation, including Q&A

A webcast of the event can be accessed on the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived on the Company's website for 90 days.

About the Conference
The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com  and follow us on Twitter under @ESSAPharma.

Cision View original content:http://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-bloom-burton--co-healthcare-investor-conference-301268268.html

SOURCE ESSA Pharma Inc

FAQ

When is ESSA Pharma's presentation at the Bloom Burton & Co. Healthcare Investor Conference?

ESSA Pharma's presentation is scheduled for April 20, 2021, at 11:00 AM ET.

Who will present for ESSA Pharma at the conference?

Dr. David R. Parkinson, CEO, will present, along with COO Peter Virsik and CFO David S. Wood.

How long will the ESSA Pharma presentation last?

The presentation will last for 30 minutes, including a Q&A session.

Where can I watch the ESSA Pharma conference presentation?

The presentation can be accessed via a webcast on ESSA Pharma's website.

What is the focus of ESSA Pharma?

ESSA Pharma focuses on developing novel therapies for the treatment of prostate cancer.

ESSA Pharma Inc.

NASDAQ:EPIX

EPIX Rankings

EPIX Latest News

EPIX Stock Data

77.01M
43.38M
2.26%
81.19%
2.59%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER